Search clinical trials for: AbobotulinumtoxinA (ABO)

Total 3407 results

AbbVie

Completed

Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects

Healthy Volunteer

China
University of California, San Francisco

Recruiting

DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

Spasmodic Dysphonia | Adductor Spasmodic Dysphonia | Voice Disorders

United States
RMW Testing

Active, not recruiting

A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

COPD

United States
Allergan

Completed

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence

Platysma Prominence

United States, Canada
Allergan

Completed

A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Glabellar Lines

United States
Galderma R&D

Completed

A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

Frown Lines

United States, Canada
Cady, Roger, M.D.
Allergan

Completed

Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine

Chronic Migraine

United States
Carruthers Dermatology Centre
Allergan

Completed

Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration.

Skin Wrinkling

United States, Canada
Andreas Nikolis

Completed

BOTOX® Cosmetic and Skin Health.

Oily Skin

Canada
University of California, Irvine
Allergan

Completed

Functional Effects of Botox on the Brain Using MRS and fMRI

Healthy

United States
Washington University School of Medicine

Withdrawn

Botox for Treatment of TMJ Disorder With Bruxism (TMJ)

Bruxism | Temporomandibular Joint Disorders | Temporomandibular Joint Dysfunction Syndrome | Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint

United States
St. Luke's-Roosevelt Hospital Center
Allergan

Terminated

OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study

New Daily Persistent Headache

United States
Changhua Christian Hospital

Completed

Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients

Stroke | Spasticity

Taiwan
University of Maryland, Baltimore
Johns Hopkins University; Harvard School of Public Health (HSPH)

Recruiting

Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention

Infections | Inflammation | Overweight and Obesity | Respiratory Disease | Insufficient Sleep | Body Mass Index | Allergies | Congestion | Skin Conditions | Antibiotic Use | Digestive Disease

United States
Pomeranian Medical University Szczecin
Charite University, Berlin, Germany; Imperial College London; SANPROBI SPOLKA... and other collaborators

Recruiting

The Efficacy of Pasteurised Akkermansia Muciniphila in Healthy Medical Workers (MENTAkHEALTH)

Healthy | Stress | Dietary Supplement

Poland
Bristol-Myers Squibb

Recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult and Adolescent Participants With Alpha (α)-Thalassemia

Anemia

Thailand, China, Canada, Turkey, Greece, Taiwan, Italy, Hong Kong
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia (APL0618)

Acute Promyelocytic Leukemia

Italy
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Ebola Disease | Immunisation

United States
AbbVie

Terminated

Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Myelofibrosis (MF)

United States, Korea, Republic of, South Africa
University of California, Los Angeles

Completed

Attention Training for Underserved Youth With Anxiety

Anxiety

United States
Assembly Biosciences

Terminated

ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Mild

United States, Canada
AbbVie
Genentech, Inc.

Completed

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Celgene

Completed

A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Pancreatic Cancer

United States, Canada, Spain, Australia, France, Germany, Austria, Italy, Ukraine
FibroGen

Completed

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

Anemia

China
University Health Network, Toronto
Celgene Corporation

Completed

A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer

Head and Neck Cancer

Canada
Tehran University of Medical Sciences

Completed

Safety Assessment of a Multipeptide-gene Vaccine in CML

Leukemia, Myeloid, Chronic

Iran, Islamic Republic of
University Hospital Tuebingen

Recruiting

Early Antibiotic Therapy and Vaccinations in Preterm Infants

Vaccination Reaction

Germany
Tel Aviv University

Completed

ACT With Feedback for Post Traumatic Stress Disorder (PTSD)

PTSD

Israel
German Diabetes Center
Heinrich-Heine University, Duesseldorf

Completed

Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes

Obesity | Non-insulin-dependent Diabetes Mellitus

Germany
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine

Migraine

Japan
University of Alabama at Birmingham

Withdrawn

Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer (Panitumumab)

Metastatic Colon Cancer

United States
UCB Biopharma SRL

Completed

A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of Zampilimab in Healthy Participants

Healthy Study Participants

United Kingdom
AbbVie

Completed

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis (VISUAL III)

Uveitis
AbbVie (prior sponsor, Abbott)

Completed

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

Ulcerative Colitis
AbbVie

Completed

Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients (AS PMOS)

Ankylosing Spondylitis
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting (InspirAda)

Ulcerative Colitis
Ohio State University
Baxter Healthcare Corporation

Terminated

Comparison of Actifuse ABX and Local Bone in Spinal Surgery

Scoliosis | Kyphosis | Lordosis

United States
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR); University of Toronto

Completed

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2? (VALIANT Pilot)

Herpes Simplex | Human Immunodeficiency Virus

Canada
Abbott
Eisai Co., Ltd.

Completed

A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

Ankylosing Spondylitis

Japan
Abbott

Completed

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Crohn's Disease

United States, Belgium, Canada, Czech Republic, France, Netherlands, Poland, United Kingdom
Abbott

Completed

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Psoriasis

United States, Canada
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Abbott

Approved for marketing

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis (ReAct)

Rheumatoid Arthritis
National Cancer Institute (NCI)
NRG Oncology

Completed

Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial Tumor

United States
AbbVie (prior sponsor, Abbott)

Completed

Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Chronic Hepatitis C | Hepatitis C Virus (HCV) Infection

United States, Puerto Rico
Arch Oncology

Completed

Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
InQpharm Group
Analyze & Realize

Completed

Benefit of IQP-AO-101 for Sleep

Insomnia, Nonorganic

Germany
Bispebjerg Hospital

Recruiting

The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities

Chronic Pain | Lower Extremity Wound

Denmark
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States

3

Subscribe